DE69719766T2 - Zyklische etherverbindungen als natriumkanal-modulatoren - Google Patents

Zyklische etherverbindungen als natriumkanal-modulatoren Download PDF

Info

Publication number
DE69719766T2
DE69719766T2 DE69719766T DE69719766T DE69719766T2 DE 69719766 T2 DE69719766 T2 DE 69719766T2 DE 69719766 T DE69719766 T DE 69719766T DE 69719766 T DE69719766 T DE 69719766T DE 69719766 T2 DE69719766 T2 DE 69719766T2
Authority
DE
Germany
Prior art keywords
substituted
sodium channel
lower alkyl
cyclic ether
channel modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69719766T
Other languages
English (en)
Other versions
DE69719766D1 (de
Inventor
Shigenori Ohkawa
Tadatoshi Hashimoto
Kohji Fukatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69719766D1 publication Critical patent/DE69719766D1/de
Application granted granted Critical
Publication of DE69719766T2 publication Critical patent/DE69719766T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DE69719766T 1996-08-29 1997-08-28 Zyklische etherverbindungen als natriumkanal-modulatoren Expired - Lifetime DE69719766T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22884596 1996-08-29
JP8649697 1997-04-04
PCT/JP1997/003007 WO1998008842A1 (en) 1996-08-29 1997-08-28 Cyclic ether compounds as sodium channel modulators

Publications (2)

Publication Number Publication Date
DE69719766D1 DE69719766D1 (de) 2003-04-17
DE69719766T2 true DE69719766T2 (de) 2004-01-15

Family

ID=26427602

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69719766T Expired - Lifetime DE69719766T2 (de) 1996-08-29 1997-08-28 Zyklische etherverbindungen als natriumkanal-modulatoren

Country Status (10)

Country Link
US (1) US6172085B1 (de)
EP (1) EP0923575B1 (de)
CN (1) CN1076022C (de)
AT (1) ATE234298T1 (de)
AU (1) AU4031697A (de)
CA (1) CA2264231A1 (de)
DE (1) DE69719766T2 (de)
HU (1) HUP9903557A2 (de)
NO (1) NO990583D0 (de)
WO (1) WO1998008842A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69915508T2 (de) 1998-12-04 2005-01-27 Takeda Chemical Industries, Ltd. Benzofuranderivate, verfahren zu ihrer herstellung und deren verwendungen
EP1169060B1 (de) 1999-04-09 2005-08-31 Euro-Celtique S.A. Natrium kanalblocker zusammensetzungen und deren verwendung
CA2404858A1 (en) * 2000-04-12 2001-10-25 Minerva Biotechnologies Corporation Treatment of neurodegenerative disease
US6825201B2 (en) * 2001-04-25 2004-11-30 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic amidopiperazine derivatives
WO2003020273A2 (en) 2001-09-03 2003-03-13 Newron Pharmaceuticals Spa Pharmaceutical composition comprising gabapentin or an analogue thereof and an $g(a)-aminoamide and its analgesic use
ES2338539T3 (es) 2001-11-01 2010-05-10 Icagen, Inc. Pirazolamidas para uso en el tratamiento del dolor.
DE60219687T2 (de) * 2001-12-27 2007-12-27 Ortho-Mcneil Pharmaceutical, Inc. Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems
US20030236277A1 (en) 2002-02-14 2003-12-25 Kadow John F. Indole, azaindole and related heterocyclic pyrrolidine derivatives
AU2003219933A1 (en) 2002-02-25 2003-09-09 Vanderbilt University Expression system for human brain-specific voltage-gated sodium channel, type 1
US7037913B2 (en) 2002-05-01 2006-05-02 Bristol-Myers Squibb Company Bicyclo 4.4.0 antiviral derivatives
ES2420932T3 (es) * 2003-06-26 2013-08-27 Takeda Pharmaceutical Company Limited Modulador del receptor de cannabinoides
KR20070046136A (ko) * 2004-08-27 2007-05-02 다케다 야쿠힌 고교 가부시키가이샤 아조 화합물과 그 제조 방법
US20060100209A1 (en) * 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
DE102004061593A1 (de) 2004-12-21 2006-06-22 Abbott Gmbh & Co. Kg Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
US7598380B2 (en) * 2005-08-03 2009-10-06 Bristol-Myers Squibb Company Method of preparation of azaindole derivatives
EP1922068A4 (de) 2005-08-16 2010-08-11 Icagen Inc Inhibitoren von spannungsgesteuerten natriumkanälen
US7705158B2 (en) 2005-11-02 2010-04-27 Icagen, Inc. Inhibitors of ion channels
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
JP5361857B2 (ja) * 2007-03-23 2013-12-04 ファイザー・リミテッド イオンチャネルの阻害剤
EP2173743A2 (de) * 2007-07-13 2010-04-14 Icagen, Inc. Natriumkanalinhibitoren
CN103554002B (zh) * 2013-10-08 2016-04-27 常州大学 1-苯基吲哚及其制备方法
US10752588B2 (en) * 2014-12-19 2020-08-25 The Broad Institute, Inc. Dopamine D2 receptor ligands
WO2016100940A1 (en) 2014-12-19 2016-06-23 The Broad Institute, Inc. Dopamine d2 receptor ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE68675B1 (en) * 1990-11-01 1996-07-10 Takeda Chemical Industries Ltd Aminocoumaran derivatives their production and use
JP3198395B2 (ja) * 1992-05-28 2001-08-13 武田薬品工業株式会社 アミノクマラン誘導体
TW334433B (en) 1992-12-09 1998-06-21 Takeda Pharm Industry Co Ltd Crystalline salt of (S)-(+)-5-amino-2,4,6,7-tetramethyl-2-(4-phenylpiperidinomethyl)-2,3-dihydrobenzo(b)furan dihydrochloride their production and use

Also Published As

Publication number Publication date
NO990583L (no) 1999-02-08
DE69719766D1 (de) 2003-04-17
US6172085B1 (en) 2001-01-09
AU4031697A (en) 1998-03-19
EP0923575B1 (de) 2003-03-12
CN1223652A (zh) 1999-07-21
ATE234298T1 (de) 2003-03-15
CN1076022C (zh) 2001-12-12
EP0923575A1 (de) 1999-06-23
HUP9903557A2 (en) 2002-08-28
NO990583D0 (no) 1999-02-08
CA2264231A1 (en) 1998-03-05
WO1998008842A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
DE69719766D1 (de) Zyklische etherverbindungen als natriumkanal-modulatoren
HUP9701169A2 (hu) Cikloalkano-piridin-származékok, intermedierjeik, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
DK0941218T3 (da) Antithrombotiske organiske nitrater
DE69903976T2 (de) Heteroaryl-zyklische acetale
EA200100428A1 (ru) Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты)
DE69834508D1 (de) Aptoptoseinhibitoren
NZ332781A (en) Mouthwash composition comprising cetylpyridinium chloride and an amphoteric surfactant
DK1114076T3 (da) Acceleratorer til hærdbare systemer
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
FI851934A0 (fi) Kefalosporinderivat.
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
FR2659653B1 (fr) Derives de l'uree, leur preparation et les medicaments les contenant.
MX9700365A (es) Uso de benzaldehidos para asignar hidrocarburos.
MY109319A (en) Cyclohexane and tetrahydropyran derivatives.
SE8303913L (sv) Heterocykliska foreningar
YU46216B (sh) Karbociklicno in heterociklicno anelirani dihidropiridini
FI870460A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-substituerade oktahydroindolizinderivat och vid foerfarandet anvaendbara mellanprodukter.
ATE55907T1 (de) Oktahydroindolizine brauchbar als analgetika.
EA200200665A1 (ru) Новые соединения бензолсульфонамида, способ их получения и фармацевтические композиции, их содержащие
TR199802517T2 (xx) Dibenzo-Oksazepin ve-Dioksepin, Bunlar�n Anti-T�m�r Maddeleri Olarak Kullan�mlar�.
DE3783279D1 (de) Substituierte furazane.
DE69521895D1 (de) Indolderivate als prodrugs von "5-ht1-like" rezeptor agonisten
MY129238A (en) Anticonvulsant derivatives useful in treating essential tremor
ES8703457A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiacetona.
CA2245926A1 (en) 7-phenyl-1,4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP